Status:

COMPLETED

Toujeo Versus NPH Self-titration Study

Lead Sponsor:

Elaine Chow

Collaborating Sponsors:

Sanofi

Conditions:

Diabetes Mellitus, Type 2

Eligibility:

All Genders

18-75 years

Phase:

PHASE4

Brief Summary

This is a 24 week, multicentre, prospective, randomized, controlled, parallel-designed (1:1) pilot study.The study will compare glycemic variability in patients treated with insulin glargine U300/ml i...

Eligibility Criteria

Inclusion

  • Type 2 diabetic suboptimally controlled on their previous antidiabetic treatment
  • 18 ≤ age ≤ 75
  • Stable dose of oral antidiabetic treatment for \> 8 weeks
  • The number of OADs that the patients used should be "3" or less
  • HbA1c level \> 7.0% and \< 10%
  • Fasting plasma glucose \> 8mmol/L and \<15mmol
  • BMI \< 40 kg/m2
  • Patient who is capable and willing to perform regular SMBG
  • Patient who is capable and willing for insulin injection
  • Confirmed written consent
  • Insulin naïve

Exclusion

  • Participation in a clinical trial with any investigational drug used with curative intent and within 30 days prior to study entry
  • Patient known to have hypoglycaemia unawareness or recurrent major hypoglycaemia
  • Any product containing prandial insulin
  • Concomitant medication known to interface with glucose metabolism (such as systematic steroids)
  • Change in dose of non-insulin anti-diabetic treatment or initiation of new anti-diabetic medications in the last 8 weeks prior to screening
  • Patients treated with steroid or nonsteroidal anti-inflammatory drugs
  • Patient who had experienced an acute concurrent illness during the 3-month period before the investigation
  • Patient with hepatic disease and end-stage renal disease
  • Patients unable to comply with follow-up visits
  • Pregnant or breastfeeding women

Key Trial Info

Start Date :

January 1 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2020

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT03389490

Start Date

January 1 2018

End Date

May 1 2020

Last Update

August 3 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Prince of Wales Hospital

Hong Kong, Shatin, Hong Kong